| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |